{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T05:10:12Z","timestamp":1747804212401,"version":"3.41.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hainan Joint General Project of Health Science and Technology Innovation","award":["WSJK2024MS223","WSJK2024MS223"],"award-info":[{"award-number":["WSJK2024MS223","WSJK2024MS223"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02600-5","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:37:04Z","timestamp":1747802224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study on the molecular mechanism of UBA52 and BARD1 regulating hepatocellular carcinoma through the PI3 K\/AKT signaling pathway"],"prefix":"10.1007","volume":"16","author":[{"given":"Chenrui","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"3","key":"2600_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"2600_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10360","key":"2600_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"issue":"7","key":"2600_CR4","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"A Ally","year":"2017","unstructured":"Ally A, Balasundaram M, Carlsen R, et al. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169(7):1327-1341.e23.","journal-title":"Cell"},{"issue":"1","key":"2600_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccell.2023.11.010","volume":"42","author":"Y Sun","year":"2024","unstructured":"Sun Y, Wu P, Zhang Z, et al. Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma. Cancer Cell. 2024;42(1):135-156.e17.","journal-title":"Cancer Cell"},{"key":"2600_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116483","volume":"174","author":"A Abusaliya","year":"2024","unstructured":"Abusaliya A, Bhosale PB, Kim HH, et al. Investigation of prunetrin induced G2\/M cell cycle arrest and apoptosis via Akt\/mTOR\/MAPK pathways in hepatocellular carcinoma cells. Biomed Pharmacother. 2024;174: 116483.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"2600_CR7","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s41416-024-02849-7","volume":"131","author":"C Dantzer","year":"2024","unstructured":"Dantzer C, Dif L, Vach\u00e9 J, Basbous S, Billottet C, Moreau V. Specific features of \u00df-catenin-mutated hepatocellular carcinomas. Br J Cancer. 2024;131(12):1871\u201380.","journal-title":"Br J Cancer"},{"issue":"2","key":"2600_CR8","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220531","volume":"306","author":"A Kitao","year":"2022","unstructured":"Kitao A, Matsui O, Zhang Y, et al. Dynamic CT and gadoxetic acid-enhanced MRI characteristics of P53-mutated hepatocellular carcinoma. Radiology. 2022;306(2): e220531.","journal-title":"Radiology"},{"key":"2600_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217088","volume":"598","author":"Y Wu","year":"2024","unstructured":"Wu Y, Wang J, Zhao J, et al. LTR retrotransposon-derived LncRNA LINC01446 promotes hepatocellular carcinoma progression and angiogenesis by regulating the SRPK2\/SRSF1\/VEGF axis. Cancer Lett. 2024;598: 217088.","journal-title":"Cancer Lett"},{"issue":"1","key":"2600_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7150\/ijbs.66913","volume":"18","author":"D Chen","year":"2022","unstructured":"Chen D, Liu J, Zang L, et al. Integrated machine learning and bioinformatic analyses constructed a novel stemness-related classifier to predict prognosis and immunotherapy responses for hepatocellular carcinoma patients. Int J Biol Sci. 2022;18(1):360\u201373.","journal-title":"Int J Biol Sci"},{"key":"2600_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2024.2395727","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Chen S, Jun S, et al. MLKL-USP7-UBA52 signaling is indispensable for autophagy in brain through maintaining ubiquitin homeostasis. Autophagy. 2025. https:\/\/doi.org\/10.1080\/15548627.2024.2395727.","journal-title":"Autophagy"},{"issue":"1","key":"2600_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41421-023-00590-8","volume":"9","author":"D Wu","year":"2023","unstructured":"Wu D, Huang H, Chen T, et al. The BRCA1\/BARD1 complex recognizes pre-ribosomal RNA to facilitate homologous recombination. Cell Discov. 2023;9(1):99.","journal-title":"Cell Discov"},{"issue":"10127","key":"2600_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301\u201314.","journal-title":"Lancet"},{"key":"2600_CR14","first-page":"109","volume":"82","author":"A Chan","year":"2020","unstructured":"Chan A, Kow A, Hibi T, Di Benedetto F, Serrablo A. Liver resection in cirrhotic liver: are there any limits. Liver Transplant Hepatobil Surg Int J Surg. 2020;82:109\u201314.","journal-title":"Liver Transplant Hepatobil Surg Int J Surg"},{"key":"2600_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000225","author":"Z Yu","year":"2023","unstructured":"Yu Z, Keskinocak P, Magliocca JF, Romero R, Sokol J. Split or whole liver transplantation? Utilization and posttransplant survival. Hepatol Commun. 2023. https:\/\/doi.org\/10.1097\/HC9.0000000000000225.","journal-title":"Hepatol Commun"},{"key":"2600_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.102610","author":"S Xia","year":"2020","unstructured":"Xia S, Pan Y, Liang Y, Xu J, Cai X. The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma. EBioMedicine. 2020. https:\/\/doi.org\/10.1016\/j.ebiom.2019.102610.","journal-title":"EBioMedicine"},{"key":"2600_CR17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154515","author":"C Xu","year":"2022","unstructured":"Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X. \u03b2-Catenin signaling in hepatocellular carcinoma. J Clin Investig. 2022. https:\/\/doi.org\/10.1172\/JCI154515.","journal-title":"J Clin Investig"},{"key":"2600_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103302","volume":"75","author":"B Sun","year":"2024","unstructured":"Sun B, Ding P, Song Y, et al. FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. 2024;75: 103302.","journal-title":"Redox Biol"},{"issue":"11","key":"2600_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.molmed.2019.06.007","volume":"25","author":"J Chen","year":"2019","unstructured":"Chen J, Gingold JA, Su X. Immunomodulatory TGF-\u03b2 signaling in hepatocellular carcinoma. Trends Mol Med. 2019;25(11):1010\u201323.","journal-title":"Trends Mol Med"},{"issue":"6","key":"2600_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/gutjnl-2023-331342","volume":"73","author":"N Cai","year":"2024","unstructured":"Cai N, Cheng K, Ma Y, et al. Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy. Gut. 2024;73(6):985.","journal-title":"Gut"},{"key":"2600_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32693","author":"B Liang","year":"2023","unstructured":"Liang B, Wang H, Qiao Y, et al. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis. Hepatology. 2023. https:\/\/doi.org\/10.1002\/hep.32693.","journal-title":"Hepatology"},{"issue":"11","key":"2600_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007479","volume":"11","author":"J Yu","year":"2023","unstructured":"Yu J, Ling S, Hong J, et al. TP53\/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma. J ImmunoTherapy Cancer. 2023;11(11): e007479.","journal-title":"J ImmunoTherapy Cancer"},{"issue":"5","key":"2600_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/nar\/19.5.1035","volume":"19","author":"RT Baker","year":"1991","unstructured":"Baker RT, Board PG. The human ubiquitin-52 amino acid fusion protein gene shares several structural features with mammalian ribosomal protein genes. Nucleic Acids Res. 1991;19(5):1035\u201340.","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"2600_CR24","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.7150\/thno.97005","volume":"14","author":"Y Yao","year":"2024","unstructured":"Yao Y, Xu T, Li X, et al. Selenoprotein S maintains intestinal homeostasis in ulcerative colitis by inhibiting necroptosis of colonic epithelial cells through modulation of macrophage polarization. Theranostics. 2024;14(15):5903\u201325.","journal-title":"Theranostics"},{"key":"2600_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119583","volume":"586","author":"M Mughees","year":"2020","unstructured":"Mughees M, Wajid S, Samim M. Cytotoxic potential of Artemisia absinthium extract loaded polymeric nanoparticles against breast cancer cells: Insight into the protein targets. Int J Pharm. 2020;586: 119583.","journal-title":"Int J Pharm"},{"issue":"4","key":"2600_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/cas.13951","volume":"110","author":"Q Zhou","year":"2019","unstructured":"Zhou Q, Hou Z, Zuo S, et al. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with 52. Cancer Sci. 2019;110(4):1194\u2013207.","journal-title":"Cancer Sci"},{"issue":"1","key":"2600_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41698-023-00446-0","volume":"7","author":"SM Setayesh","year":"2023","unstructured":"Setayesh SM, Ndacayisaba LJ, Rappard KE, et al. Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma. NPJ Precis Oncol. 2023;7(1):95.","journal-title":"NPJ Precis Oncol"},{"issue":"6","key":"2600_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18164","volume":"28","author":"L Tong","year":"2024","unstructured":"Tong L, Zheng X, Wang T, et al. Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression. J Cell Mol Med. 2024;28(6): e18164.","journal-title":"J Cell Mol Med"},{"key":"2600_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108009","volume":"232","author":"M Russi","year":"2022","unstructured":"Russi M, Marson D, Fermeglia A, et al. The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer. Pharmacol Ther. 2022;232: 108009.","journal-title":"Pharmacol Ther"},{"issue":"17","key":"2600_CR30","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1093\/nar\/gkad631","volume":"51","author":"L Qiu","year":"2023","unstructured":"Qiu L, Xu W, Lu X, et al. The HDAC6-RNF168 axis regulates H2A\/H2A.X ubiquitination to enable double-strand break repair. Nucleic Acids Res. 2023;51(17):9166\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"8033","key":"2600_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-024-07909-9","volume":"634","author":"I Ceppi","year":"2024","unstructured":"Ceppi I, Dello Stritto MR, M\u00fctze M, et al. Mechanism of BRCA1\u2013BARD1 function in DNA end resection and DNA protection. Nature. 2024;634(8033):492\u2013500.","journal-title":"Nature"},{"issue":"7","key":"2600_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.tibs.2022.03.001","volume":"47","author":"SR Witus","year":"2022","unstructured":"Witus SR, Zhao W, Brzovic PS, Klevit RE. BRCA1\/BARD1 is a nucleosome reader and writer. Trends Biochem Sci. 2022;47(7):582\u201395.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"2600_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/jnci\/djad182","volume":"116","author":"MP Randall","year":"2024","unstructured":"Randall MP, Egolf LE, Vaksman Z, et al. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma. JNCI J Natl Cancer Inst. 2024;116(1):138\u201348.","journal-title":"JNCI J Natl Cancer Inst."},{"key":"2600_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071848","author":"A Jain","year":"2022","unstructured":"Jain A, McCoy M, Coats C, et al. HuR plays a role in double-strand break repair in pancreatic cancer cells and regulates functional BRCA1-associated-ring-domain-1(BARD1) isoforms. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14071848.","journal-title":"Cancers (Basel)."},{"key":"2600_CR35","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/JHC.S462168","volume":"11","author":"YK Li","year":"2024","unstructured":"Li YK, Wu S, Wu YS, Zhang WH, Wang Y, Li YH, et al. Portal venous and hepatic arterial coefficients predict post-hepatectomy overall and recurrence-free survival in patients with hepatocellular carcinoma: a retrospective study. J Hepatocell Carcinoma. 2024;11:1389\u2013402. https:\/\/doi.org\/10.2147\/JHC.S462168.","journal-title":"J Hepatocell Carcinoma"},{"issue":"6","key":"2600_CR36","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.12182\/20241160605","volume":"55","author":"Y Liang","year":"2024","unstructured":"Liang Y, Li L, Liu B, Gao J, Chen X, Li J, et al. Research advances in the roles of high-altitude hypoxic stress in hepatocellular carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024;55(6):1436\u201345. https:\/\/doi.org\/10.12182\/20241160605.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban."},{"key":"2600_CR37","doi-asserted-by":"publisher","first-page":"1519999","DOI":"10.3389\/fimmu.2024.1519999","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Liang YB, Wang QB, Li YK, Chen XM, Luo WL, et al. Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis. Front Immunol. 2024;15:1519999. https:\/\/doi.org\/10.3389\/fimmu.2024.1519999.","journal-title":"Front Immunol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02600-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:37:06Z","timestamp":1747802226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02600-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2600"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02600-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Danzhou People's Hospital (Danzhou People's Hospital Medical Group). The research was carried out following the guidelines of the ethics committee listed in the ethics statement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"840"}}